Pathophysiology of oxidative stress in diabetes mellitus

Altshuler, 1949, Histochemical studies on the pathogenesis of fibrinoid, American Journal of Pathology, 25, 1061 Astrup, 1956, Biological significance of fibrinolysis, The Lancet, 2, 565, 10.1016/S0140-6736(56)92048-7 Bagglioni, 1998, Chemokines and leukocyte traffic, Nature, 392, 565, 10.1038/33340 Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diabetes.40.4.405 Belisario, 1997, Metal-ion catalyzed oxidation affects fibrinogen activity on platelet aggregation and adhesion, Biochimie, 79, 449, 10.1016/S0300-9084(97)86155-X Berlett, 1997, Protein oxidation in aging, disease, and oxidative stress, Journal of Biological Chemistry, 272, 20313, 10.1074/jbc.272.33.20313 Berliner, 1990, Minimally modified low density lipoprotein stimulates monocyte endothelial interactions, Journal of Clinical Investigation, 85, 1260, 10.1172/JCI114562 Biewenga, 1997, The pharmacology of the antioxidant lipoic acid, General Pharmacology, 29, 315, 10.1016/S0306-3623(96)00474-0 Borcea, 1999, Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria, Free Radical Biology & Medicine, 26, 1495, 10.1016/S0891-5849(99)00011-8 Cantero, 1998, Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients, Diabetes Care, 21, 326, 10.2337/diacare.21.2.326 Capeillere-Blandin, 1991, Structural modifications of human beta microglobulin treated with oxygen-derived radicals, Biochemical Journal, 277, 175, 10.1042/bj2770175 Ceriello, 1993, Coagulation activation in diabetes mellitus: the role hyperglycaemia and therapeutic prospects, Diabetologia, 36, 1119, 10.1007/BF00401055 Ceriello, 1997, Fibrinogen and diabetes mellitus: is it time for intervention trials?, Diabeteologia, 40, 731, 10.1007/s001250050741 Ceriello, 1999, Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications, Diabetes, Nutrition & Metabolism, 12, 42 Chowienczyk, 2000, Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type 2 diabetes, Diabetologia, 43, 974, 10.1007/s001250051478 Collier, 1992, Free radical activity and hemostatic fatcors in NIDDM patients with and without microalbuminuria, Diabetes, 41, 909, 10.2337/diabetes.41.8.909 Colwell, 1999, Inflammation and diabetic vascular complications, Diabetes Care, 22, 1927, 10.2337/diacare.22.12.1927 Cook, 1990, Fibrinogen as a major risk factor in cardiovascular disease, Trends in Pharmacological Sciences, 11, 444, 10.1016/0165-6147(90)90125-R Cristol, 1998, Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection, Transplantation, 65, 1322, 10.1097/00007890-199805270-00007 Cunningham, 2000, Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis, Journal of Experimental Medicine, 191, 455, 10.1084/jem.191.3.455 Danesh, 1998, Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies, JAMA, the Journal of the American Medical Association, 279, 1477, 10.1001/jama.279.18.1477 Davie, 1992, Effect of vitamin C on glycosylation of proteins, Diabetes, 41, 167, 10.2337/diabetes.41.2.167 Davies, 1987, Protein damage and degradation by oxygen radicals: I. General aspects, Journal of Biological Chemistry, 262, 9895, 10.1016/S0021-9258(18)48018-0 Davies, 1987, Protein damage and degradation by oxygen radicals: IV. Degradation of denatured protein, Journal of Biological Chemistry, 262, 9914, 10.1016/S0021-9258(18)48021-0 de Lorgeril, 1993, Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis, American Heart Journal, 125, 974, 10.1016/0002-8703(93)90103-G Deneke, 2000, Thiol-based antioxidants, Current Topics in Cell Regulation, 36, 151, 10.1016/S0070-2137(01)80007-8 Devaraj, 2000, Oxidative stress and antioxidants in Type 2 diabetes, 117 Duguid, 1946, Thrombosis as a factor in the pathogenesis of coronary atherosclerosis, Journal of Pathology and Bacteriology, 58, 207, 10.1002/path.1700580207 Esterbauer, 1992, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Radical Biology & Medicine, 13, 341, 10.1016/0891-5849(92)90181-F Ford, 1999, Body mass index, diabetes, and C-reative protein among US adults, Diabetes Care, 22, 1971, 10.2337/diacare.22.12.1971 Frei, 1988, Antioxidant defenses and lipid peroxidation in human blood plasma, Proceedings of the National Academy of Sciences of the United States of America, 85, 9748, 10.1073/pnas.85.24.9748 Fuller, 1996, RRR-alpha-tocopherol acetate supplementation at pharmacologic doses decreases LDL oxidative susceptibility but not protein glycation in patients with DM, American Journal of Clinical Nutrition, 63, 753, 10.1093/ajcn/63.5.753 Galli, 1999, Biological effects of oxidant stress in hemodialysis: the possible role of vitamin E, Blood Purification, 17, 79, 10.1159/000014379 Ganda, 1992, Hyperfibrinogenemia: an important risk factor for vascular complication in diabetes, Diabetes Care, 15, 1245, 10.2337/diacare.15.10.1245 Ghanem, 1996, Increased LDL oxidation in stable kidney transplant recipients, Kidney International, 49, 488, 10.1038/ki.1996.69 Grau, 1996, The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular disease, Thrombosis Research, 82, 245, 10.1016/0049-3848(96)00071-0 Grimm, 1985, Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality, JAMA, the Journal of the American Medical Association, 254, 1932, 10.1001/jama.254.14.1932 Gurewich, 1979, Activation I of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: pathogenetic differences, Thrombosis Research, 14, 931, 10.1016/0049-3848(79)90011-2 Gutterridge, 1990, The measurement and mechanism of lipid peroxidation in biological systems, Trends in Biochemical Sciences, 15, 129, 10.1016/0968-0004(90)90206-Q Haak, 1999, The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neurophathy assessed by capillary microscopy, Microvascular Research, 58, 28, 10.1006/mvre.1999.2151 Haffner, 2000, Coronary heart disease in patients with diabetes, New England Journal of Medicine, 342, 1040, 10.1056/NEJM200004063421408 Hashimoto, 1999, Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease, Journal of Biological Chemistry, 274, 28849, 10.1074/jbc.274.41.28849 Held, 2000, Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study, Atherosclerosis, 148, 179, 10.1016/S0021-9150(99)00240-3 Henschen-Edman, 1997, Photo-oxidation of histidine as a probe for aminoterminal conformational changes during fibrinogen–fibrin conversion, Cellular and Molecular Life Sciences, 53, 29, 10.1007/PL00000577 Ho, 1999, Antioxidants, NFkB activation, and diabetogenesis, Proceedings of the Society for Experimental Biology and Medicine, 222, 205, 10.1046/j.1525-1373.1999.d01-137.x Holvoet, 1996, Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure, Thrombosis and Haemostasis, 76, 663, 10.1055/s-0038-1650639 Horie, 1992, Identified diallyl polysulfides from an aged garlic extract which protects the membranes from lipid peroxydation, Planta Medica, 58, 468, 10.1055/s-2006-961517 Huggins, 1993, Formation of o-tyrosine and dityrosine in protein during radilytic and metal-catalyzed oxidation, Journal of Biological Chemistry, 268, 12341, 10.1016/S0021-9258(18)31395-4 Ide, 1999, Aged garlic extract attenuates intracellular oxidative stress, Phytomedicine, 6, 125, 10.1016/S0944-7113(99)80047-6 Irish, 1998, Cardiovascular disease, fibrinogen and the acute phase response. Association with lipids and blood pressure in patients with chronic renal disease, Atherosclerosis, 137, 133, 10.1016/S0021-9150(97)00273-6 Islam, 2000, Alpha-tocopherol supplementation decerases oxidative susceptibility of LDL in renal failure patients on dialysis therapy, Atherosclerosis, 150, 217, 10.1016/S0021-9150(99)00410-4 Kannel, 1987, Fibrinogen and risk of cardiovascular disease. The Framingham study, JAMA, the Journal of the American Medical Association, 258, 1183, 10.1001/jama.258.9.1183 Kanwar, 1999, Structure and stability of the dityrosine-linked dimer of gammaB-crystallin, Experimental Eye Research, 68, 773, 10.1006/exer.1999.0669 Karpel, 1991, Free radical induced fibrinogen coagulation: modulation of neofibe formation by concentration, pH, and temperature, Israel Medical Journal, 27, 61 Keaney, 1999, Vitamin E and vascular homeostasis: implications for atherosclerosis, FASEB Journal, 13, 965, 10.1096/fasebj.13.9.965 Kleinveld, 1994, Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Wanatabe heritable hyperlipidemic rabbits, Arteriosclerosis and Thrombosis, 14, 1386, 10.1161/01.ATV.14.8.1386 Kostis, 1984, Association between leukocyte count and presence and extent of coronary atherosclerosis as determined by corona sry arteriography, American Journal of Cardiology, 53, 997, 10.1016/0002-9149(84)90624-6 Kowluru, 2000, Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy, Free Radical Research, 32, 67, 10.1080/10715760000300071 Kuller, 2000, Diabetes mellitus. Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality, Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 823, 10.1161/01.ATV.20.3.823 Landin, 1990, Elevated fibrinogen and PAI-1 in hypertension and related to to metabolic risk in CVD, Journal of Internal Medicine, 227, 273, 10.1111/j.1365-2796.1990.tb00157.x Latallo, 1964, Inhibition of thrombin and of fibrin polymerization, two activities derived from plasmin-digested fibrinogen, Nature, 2013, 1184, 10.1038/2031184a0 Leeuwenburgh, 1997, Reactive nitrogen intermediates promotes LDL oxidation in human atherosclerotic intima, Journal of Biological Chemistry, 272, 1433, 10.1074/jbc.272.3.1433 Leeuwenburgh, 1997, Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in LDL isolated from human athersosclerotic plaques, Journal of Biological Chemistry, 272, 3520, 10.1074/jbc.272.6.3520 Lefer, 2000, Oxidative stress and cardiac disease, American Journal of Medicine, 109, 315, 10.1016/S0002-9343(00)00467-8 Leinonen, 1998, Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients, Clinica Chimica Acta, 275, 163, 10.1016/S0009-8981(98)00083-7 Levenson, 1995, Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors, Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1269, 10.1161/01.ATV.15.9.1263 Lijinen, 1996, Impaired fibrinolysis and the risk for coronary heart disease, Circulation, 94, 2052, 10.1161/01.CIR.94.9.2052 Lipinski, 1993, Effect of thiol-induced disulfide exchange in proteins on plasma clotting and fibrinolysis, Thrombosis and Haemostasis, 69, 1260 Lipinski, 1995, Plasma macromolecular protein complex: interaction with fibrin and fibrinolysis, Thrombosis Research, 78, 461, 10.1016/0049-3848(95)99613-D Lipinski, 1974, The organ distribution of 125I-fibrin in the generalized Shwartzman reaction and its relation to leukocytes, British Journal of Haematology, 28, 221, 10.1111/j.1365-2141.1974.tb06657.x Lorenz, 1998, High doses of methylene blue/light treatment crosslink the A alpha subunit of fibrinogen: influence of this photooxidation on fibrinogen binding to platelets, Haemostasis, 28, 17 Loughrey, 1993, Oxidative stress in hemodialysis, Quarterly Journal of Medicine, 87, 679 Marx, 1985, Fibrinogen coagulation without thrombin: reaction with vitamin C and copper(II), Thrombosis Research, 40, 11, 10.1016/0049-3848(85)90345-7 Maser, 1991, Cardiovascular disease and arterial calcification in IDDM: interrelations and risk factor profiles, Arteriosclerosis and Thrombosis, 11, 958, 10.1161/01.ATV.11.4.958 Matteucci, 2000, Oxidative sterss in families of type 1 diabetic patients, Diabetes Care, 23, 1182, 10.2337/diacare.23.8.1182 Mechta, 1989, Neutrophil function in ischemic heart disease, Circulation, 79, 549, 10.1161/01.CIR.79.3.549 Missov, 1996, Plasma fibrinogen levels in NIDDM: the Rotterdam study, Diabetes Care, 19, 157, 10.2337/diacare.19.2.157 Miyata, 1999, Origin and significance of carbonyl stress in long-term uremic complications, Kidney International, 55, 389, 10.1046/j.1523-1755.1999.00302.x Miyazaki, 2000, Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer, Circulation, 101, 1002, 10.1161/01.CIR.101.9.1002 Morel, 1994, Treatment of cholesterol-fed rabbits with dietary vitamin E and C inhibits lipoprotein oxidation but not development of atherosclerosis, Journal of Nutrition, 124, 2123, 10.1093/jn/124.11.2123 Munro, 1988, The pathogensis of atherosclerosis: atherogenesis and inflammation, Laboratory Investigation, 58, 249 O'Brien, 1996, Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized LDL, Circulation, 94, 1216, 10.1161/01.CIR.94.6.1216 O'Brien, 2000, In vitro and in vivo antioxidant properties of gliclazide, Journal of Diabetes and Its Complication, 14, 201, 10.1016/S1056-8727(00)00084-2 Odetti, 1996, Protein oxidation in hemodialysis and kidney transplantation, Metabolism, 45, 1319, 10.1016/S0026-0495(96)90108-0 Oranje, 1999, Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes, Diabetes Care, 22, 2083, 10.2337/diacare.22.12.2083 Pennathrur, 1999, Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease, Journal of Biological Chemistry, 274, 34621, 10.1074/jbc.274.49.34621 Pyorala, 1987, Diabetes and atherosclerosis: an epidemiologic view, Diabetes Metabolism Review, 3, 463, 10.1002/dmr.5610030206 Rao, 1996, Antioxidants, atherosclerosis and thrombosis, Prostaglandins, Leukotrienes and Essential Fatty Acids, 54, 155, 10.1016/S0952-3278(96)90011-3 Retzinger, 1998, Adsorption of fibrinogen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications, Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1948, 10.1161/01.ATV.18.12.1948 Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, New England Journal of Medicine, 342, 836, 10.1056/NEJM200003233421202 Rokitansky, 1952, Abnormal conditions of the arteries, vol. 4, 144 Ruhnaut, 1999, Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diaberic polyneuropathy, Diabetic Medicine, 16, 1040, 10.1046/j.1464-5491.1999.00190.x Sagripanti, 1995, Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome, Nephron, 70, 271, 10.1159/000188604 Sakamoto, 1999, Direct observation of fibrinogen–heparinoid complexes formation using surface plasmon resonance, Bioconjugate Chemistry, 10, 538, 10.1021/bc970218j Salomaa, 1995, Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study, Circulation, 91, 284, 10.1161/01.CIR.91.2.284 Shacter, 1995, Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation, Free Radical Biology & Medicine, 18, 815, 10.1016/0891-5849(95)93872-4 Shimizu, 1986, Distinctive role of histidine-16 of the B beta chain of fibrinogen in the end-to-end association of fibrin, Proceedings of the National Academy of Sciences of the United States of America, 83, 591, 10.1073/pnas.83.3.591 Smith, 1986, Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis, Clinical Haematology, 15, 355, 10.1016/S0308-2261(18)30021-3 Souza, 2000, Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers, Journal of Biological Chemistry, 275, 18344, 10.1074/jbc.M000206200 Steinbrecher, 1992, Scavenger receptor-independent stimulation of cholesterol estirification in lipoprotein extracted from human aortic intima, Arteriosclerosis and Thrombosis, 12, 608, 10.1161/01.ATV.12.5.608 Steinbrecher, 1990, Role of oxidatively modified LDL in atherosclerosis, Free Radical Biology & Medicine, 9, 155, 10.1016/0891-5849(90)90119-4 Stevens, 2000, Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy, Diabetes, 49, 1006, 10.2337/diabetes.49.6.1006 Stief, 2000, Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood, Thrombosis Research, 97, 473, 10.1016/S0049-3848(99)00211-X Struck, 1994, Effect of red and white wine on serum lipids, platelet aggregation, oxidation products and antioxidants: a preliminary report, Nutrition Research, 14, 1811, 10.1016/S0271-5317(05)80717-1 Sutherland, 1995, Oxidation of LDL from patients with renal failure or renal transplant, Kidney International, 48, 227, 10.1038/ki.1995.288 Takemura, 1987, Glomerular deposition of cross-linked fibrin in human kidney disease, Kidney International, 32, 102, 10.1038/ki.1987.178 Upchurch, 1998, Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by Aspirin, Journal of Thrombosis and Thrombolysis, 5, 9, 10.1023/A:1008859729045 Vaziri, 1993, Coagulation and inhibitory and fibrinolytic proteins in essential hypertension, Journal of the American Society of Nephrology, 4, 222, 10.1681/ASN.V42222 Violi, 1999, Nitric oxide and its role in lipid peroxidation, Diabetes Metab Res Rev, 15, 283, 10.1002/(SICI)1520-7560(199907/08)15:4<283::AID-DMRR42>3.0.CO;2-U Wells-Knecht, 1993, Oxidized amino acids in lens proteins with age, Journal of Biological Chemistry, 268, 12348, 10.1016/S0021-9258(18)31396-6 West, 2000, Radicals and oxidative stress in diabetes, Diabetic Medicine, 17, 171, 10.1046/j.1464-5491.2000.00259.x Witko-Sarsat, 1996, Advanced oxidation protein products as a novel marker of oxidative stress in uremia, Kidney International, 49, 1304, 10.1038/ki.1996.186 Yarnell, 1991, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease, Circulation, 83, 836, 10.1161/01.CIR.83.3.836 Ziegler, 1999, Alpha-lipoic acid in the treatment of diabetic polyneuropthy in Germany: current evidence from clinical trials, Experimental and Clinical Endocrinology & Diabetes, 107, 421, 10.1055/s-0029-1212132 Zimmermann, 1999, Inflammation enhances cardiovascular risk and mortality in hemodialysis patients, Kidney International, 55, 648, 10.1046/j.1523-1755.1999.00273.x